Searched for
KAIYOMARZ MARFATIA
Buy Abbott India, target price Rs 25243 : Sharekhan by BNP ParibasAbbott India, incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 42545.46 Crore) operating in Pharmaceuticals...- CLSA retains ‘buy’ on Abbott India, raises target price to Rs 16,850The brokerage said Abbott India’s net profit for the third quarter was 30% ahead of estimate due to record EBITDA margin.
- Buy Abbott India, target Rs 8480: Dharmesh ShahBuy Abbott India Ltd. at a price target of Rs 8480.0 and a stoploss at Rs 7840 from entry point.
- Abbott India MD Rehan A Khan resignsDrug firm Abbott India today announced the resignation of its Managing Director Rehan A Khan.
Load More